
1.23 Delayed Data As of Aug 05 | ![]() Today’s Change | 0.84 Today|||52-Week Range 4.67 | -57.47% Year-to-Date |
Previous close | 1.18 |
Today’s open | 1.19 |
Day’s range | 1.17 - 1.27 |
Volume | 532,941 |
Average volume (3 months) | 463,514 |
Market cap | $43.5M |
Earnings growth (last year) | +49.98% |
Earnings growth (this year) | +1.89% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -- |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | 0.56 |
Today’s change | Today’s % change | |
---|---|---|
APMAptorum Group Ltd | -0.01 | -0.65% |
NOVNNovan Inc | +0.12 | +4.38% |
ADMPAdamis Pharmaceutica... | -0.01 | -1.76% |
--Abliva AB | 0.00 | 0.00% |
Last reporting date | August 5, 2022 |
EPS forecast (this quarter) | -$0.23 |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$37.3M |
Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Devon, Pennsylvania |